Global Biobanking Market Research Report, Competitive, Technology and Forecast Analysis 2025-2032
Description
Market Overview
According to DIResearch＇s in-depth investigation and research, the global Biobanking market size will reach 3,833.31 Million USD in 2025 and is projected to reach 6,240.52 Million USD by 2032, with a CAGR of 7.21% (2025-2032). Notably, the China Biobanking market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Biobanking refers to the collection, storage, and management of biological samples and associated data for research purposes. A biobank is an organized repository that houses a large collection of biological materials, such as blood, tissue, cells, DNA, and other bodily fluids, along with relevant clinical and demographic information. Biobanks play a crucial role in advancing biomedical research, as they provide researchers with valuable resources for studying diseases, understanding genetic variations, developing new diagnostic tests, and discovering potential therapeutic targets. These samples can be used for a wide range of research areas, including genomics, proteomics, metabolomics, and personalized medicine. The establishment and operation of a biobank involve several important considerations. Ethical and legal aspects, such as informed consent, privacy protection, and data security, are of utmost importance to ensure the proper handling and use of the stored samples and associated information. Biobanks also follow strict quality control and standardization protocols to maintain the integrity and reliability of the collected samples. Furthermore, collaboration and partnerships between biobanks, researchers, and healthcare institutions are crucial for sharing samples and data, enabling larger-scale studies and maximizing the impact of research findings. Biobanks can be categorized into different types based on their focus and scope. Population-based biobanks collect samples from a specific population or community to study diseases and their causes within that population. Disease-oriented biobanks focus on collecting samples related to a specific disease or condition, such as cancer or cardiovascular diseases. Virtual biobanks leverage existing biobanks by aggregating data and samples from multiple sources to provide a comprehensive resource for researchers. Overall, biobanking plays a vital role in biomedical research, facilitating discoveries, and advancements in understanding human health and disease. It provides researchers with access to well-characterized biological materials, fostering collaborations, and ultimately improving healthcare outcomes.
The major global suppliers of Biobanking include Thermo Fisher, Beckman Coulter, Panasonic, SOL Group, Promega, Merck, Greiner Bio One, Chart Industries, Brooks Life Science, Tecan Group, QIAGEN, BD, Lifeline Scientific, Hamilton, So-Low, TTP Labtech, Biolife Solutions, DNA Genotek, Custom Biogenic Systems, LVL Technologies, BioRep, Qingdao Haier Biomedical, OriginCell, Dashoo, Jiangsu Kangcheng Baiao Biotechnology, Takara Bio, Jiangsu Kangcheng Baiao Biotechnology, Wuxi NEST Biotechnology, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Biobanking. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Biobanking market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Biobanking market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Biobanking industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Biobanking Include:
Thermo Fisher
Beckman Coulter
Panasonic
SOL Group
Promega
Merck
Greiner Bio One
Chart Industries
Brooks Life Science
Tecan Group
QIAGEN
BD
Lifeline Scientific
Hamilton
So-Low
TTP Labtech
Biolife Solutions
DNA Genotek
Custom Biogenic Systems
LVL Technologies
BioRep
Qingdao Haier Biomedical
OriginCell
Dashoo
Jiangsu Kangcheng Baiao Biotechnology
Takara Bio
Jiangsu Kangcheng Baiao Biotechnology
Wuxi NEST Biotechnology
Biobanking Product Segment Include:
Equipment
Consumable
Biobanking Product Application Include:
Virtual Biobanks
Tissue Biobanks
Population Biobanks
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Biobanking Industry PESTEL Analysis
Chapter 3: Global Biobanking Industry Porter's Five Forces Analysis
Chapter 4: Global Biobanking Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Biobanking Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Biobanking Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Biobanking Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
According to DIResearch＇s in-depth investigation and research, the global Biobanking market size will reach 3,833.31 Million USD in 2025 and is projected to reach 6,240.52 Million USD by 2032, with a CAGR of 7.21% (2025-2032). Notably, the China Biobanking market has changed rapidly in the past few years. By 2025, China＇s market size is expected to be Million USD, representing approximately % of the global market share.
Research Summary
Biobanking refers to the collection, storage, and management of biological samples and associated data for research purposes. A biobank is an organized repository that houses a large collection of biological materials, such as blood, tissue, cells, DNA, and other bodily fluids, along with relevant clinical and demographic information. Biobanks play a crucial role in advancing biomedical research, as they provide researchers with valuable resources for studying diseases, understanding genetic variations, developing new diagnostic tests, and discovering potential therapeutic targets. These samples can be used for a wide range of research areas, including genomics, proteomics, metabolomics, and personalized medicine. The establishment and operation of a biobank involve several important considerations. Ethical and legal aspects, such as informed consent, privacy protection, and data security, are of utmost importance to ensure the proper handling and use of the stored samples and associated information. Biobanks also follow strict quality control and standardization protocols to maintain the integrity and reliability of the collected samples. Furthermore, collaboration and partnerships between biobanks, researchers, and healthcare institutions are crucial for sharing samples and data, enabling larger-scale studies and maximizing the impact of research findings. Biobanks can be categorized into different types based on their focus and scope. Population-based biobanks collect samples from a specific population or community to study diseases and their causes within that population. Disease-oriented biobanks focus on collecting samples related to a specific disease or condition, such as cancer or cardiovascular diseases. Virtual biobanks leverage existing biobanks by aggregating data and samples from multiple sources to provide a comprehensive resource for researchers. Overall, biobanking plays a vital role in biomedical research, facilitating discoveries, and advancements in understanding human health and disease. It provides researchers with access to well-characterized biological materials, fostering collaborations, and ultimately improving healthcare outcomes.
The major global suppliers of Biobanking include Thermo Fisher, Beckman Coulter, Panasonic, SOL Group, Promega, Merck, Greiner Bio One, Chart Industries, Brooks Life Science, Tecan Group, QIAGEN, BD, Lifeline Scientific, Hamilton, So-Low, TTP Labtech, Biolife Solutions, DNA Genotek, Custom Biogenic Systems, LVL Technologies, BioRep, Qingdao Haier Biomedical, OriginCell, Dashoo, Jiangsu Kangcheng Baiao Biotechnology, Takara Bio, Jiangsu Kangcheng Baiao Biotechnology, Wuxi NEST Biotechnology, etc. The global players competition landscape in this report is divided into three tiers. The first tier comprises global leading enterprises that command a substantial market share, hold a dominant industry position, possess strong competitiveness and influence, and generate significant revenue. The second tier includes companies with a notable market presence and reputation; these firms actively follow industry leaders in product, service, or technological innovation and maintain a moderate revenue scale. The third tier consists of smaller companies with limited market share and lower brand recognition, primarily focused on local markets and generating comparatively lower revenue.
This report studies the market size, price trends and future development prospects of Biobanking. Focus on analysing the market share, product portfolio, prices, sales, revenue and gross profit margin of global major suppliers, as well as the market status and trends of different product types and applications in the global Biobanking market. The report data covers historical data from 2020 to 2024, based year in 2025 and forecast data from 2026 to 2032.
The regions and countries in the report include US, Germany, Japan, China, France, UK, South Korea, Canada, Italy, Russia, Mexico, Brazil, India, Vietnam, Thailand, South Africa and other regions, covering the Biobanking market conditions and future development trends of key regions and countries, combined with industry-related policies and the latest technological developments, analyze the development characteristics of Biobanking industries in various regions and countries, help companies understand the development characteristics of each region, help companies formulate business strategies, and achieve the ultimate goal of the company's global development strategy.
The data sources of this report mainly include the National Bureau of Statistics, customs databases, industry associations, corporate financial reports, third-party databases, etc. Among them, macroeconomic data mainly comes from the National Bureau of Statistics, International Economic Research Organization; industry statistical data mainly come from industry associations; company data mainly comes from interviews, public information collection, third-party reliable databases, and price data mainly comes from various markets monitoring database.
Global Key Suppliers of Biobanking Include:
Thermo Fisher
Beckman Coulter
Panasonic
SOL Group
Promega
Merck
Greiner Bio One
Chart Industries
Brooks Life Science
Tecan Group
QIAGEN
BD
Lifeline Scientific
Hamilton
So-Low
TTP Labtech
Biolife Solutions
DNA Genotek
Custom Biogenic Systems
LVL Technologies
BioRep
Qingdao Haier Biomedical
OriginCell
Dashoo
Jiangsu Kangcheng Baiao Biotechnology
Takara Bio
Jiangsu Kangcheng Baiao Biotechnology
Wuxi NEST Biotechnology
Biobanking Product Segment Include:
Equipment
Consumable
Biobanking Product Application Include:
Virtual Biobanks
Tissue Biobanks
Population Biobanks
Chapter Scope
Chapter 1: Product Research Range, Product Types and Applications, Market Overview, Market Situation and Trend
Chapter 2: Global Biobanking Industry PESTEL Analysis
Chapter 3: Global Biobanking Industry Porter's Five Forces Analysis
Chapter 4: Global Biobanking Major Regional Market Size (Revenue) and Forecast Analysis
Chapter 5: Global Biobanking Competitive Analysis of Key Suppliers (Revenue, Market Share, Regional Distribution and Industry Concentration)
Chapter 6: Global Biobanking Revenue and Forecast Analysis by Product Type
Chapter 7: Key Company Profiles (Product Portfolio, Revenue and Gross Margin)
Chapter 8: Industrial Chain Analysis, Biobanking Different Application Market Analysis (Revenue and Forecast) and Sales Channel Analysis
Chapter 9: Research Findings and Conclusion
Chapter 10: Methodology and Data Sources
Table of Contents
165 Pages
- 1 Biobanking Market Overview
- 1.1 Product Definition and Statistical Scope
- 1.2 Biobanking Product by Type
- 1.2.1 Equipment
- 1.2.2 Consumable
- 1.3 Biobanking Product by Application
- 1.3.1 Virtual Biobanks
- 1.3.2 Tissue Biobanks
- 1.3.3 Population Biobanks
- 1.4 Global Biobanking Market Size Analysis (2020-2032)
- 1.5 Biobanking Market Development Status and Trends
- 1.5.1 Biobanking Industry Development Status Analysis
- 1.5.2 Biobanking Industry Development Trends Analysis
- 2 Biobanking Market PESTEL Analysis
- 2.1 Political Factors Analysis
- 2.2 Economic Factors Analysis
- 2.3 Social Factors Analysis
- 2.4 Technological Factors Analysis
- 2.5 Environmental Factors Analysis
- 2.6 Legal Factors Analysis
- 3 Biobanking Market Porter's Five Forces Analysis
- 3.1 Competitive Rivalry
- 3.2 Threat of New Entrants
- 3.3 Bargaining Power of Suppliers
- 3.4 Bargaining Power of Buyers
- 3.5 Threat of Substitutes
- 4 Global Biobanking Market Analysis by Country
- 4.1 Global Biobanking Market Size Analysis by Country: 2024 VS 2025 VS 2032
- 4.1.1 Global Biobanking Revenue Analysis by Country (2020-2025)
- 4.1.2 Global Biobanking Revenue Forecast Analysis by Country (2026-2032)
- 4.2 United States Biobanking Market Revenue and Growth Rate (2020-2032)
- 4.3 Germany Biobanking Market Revenue and Growth Rate (2020-2032)
- 4.4 Japan Biobanking Market Revenue and Growth Rate (2020-2032)
- 4.5 China Biobanking Market Revenue and Growth Rate (2020-2032)
- 4.6 France Biobanking Market Revenue and Growth Rate (2020-2032)
- 4.7 U.K. Biobanking Market Revenue and Growth Rate (2020-2032)
- 4.8 South Korea Biobanking Market Revenue and Growth Rate (2020-2032)
- 4.9 Canada Biobanking Market Revenue and Growth Rate (2020-2032)
- 4.10 Italy Biobanking Market Revenue and Growth Rate (2020-2032)
- 4.11 Russia Biobanking Market Revenue and Growth Rate (2020-2032)
- 4.12 Mexico Biobanking Market Revenue and Growth Rate (2020-2032)
- 4.13 Brazil Biobanking Market Revenue and Growth Rate (2020-2032)
- 4.14 India Biobanking Market Revenue and Growth Rate (2020-2032)
- 4.15 Vietnam Biobanking Market Revenue and Growth Rate (2020-2032)
- 4.16 Thailand Biobanking Market Revenue and Growth Rate (2020-2032)
- 4.17 South Africa Biobanking Market Revenue and Growth Rate (2020-2032)
- 5 Competition by Suppliers
- 5.1 Global Biobanking Market Revenue by Key Suppliers (2021-2025)
- 5.2 Biobanking Competitive Landscape Analysis and Market Dynamic
- 5.2.1 Biobanking Competitive Landscape Analysis
- 5.2.2 Global Key Suppliers Headquarter and Key Area Sales
- 5.2.3 Market Dynamic
- 6 Biobanking Market Analysis by Type
- 6.1 Global Biobanking Market Size Analysis by Type: 2024 VS 2025 VS 2032
- 6.2 Global Biobanking Revenue and Forecast Analysis by Type (2020-2032)
- 7 Key Companies Analysis
- 7.1 Thermo Fisher
- 7.1.1 Thermo Fisher Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.1.2 Thermo Fisher Biobanking Product Portfolio
- 7.1.3 Thermo Fisher Biobanking Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.2 Beckman Coulter
- 7.2.1 Beckman Coulter Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.2.2 Beckman Coulter Biobanking Product Portfolio
- 7.2.3 Beckman Coulter Biobanking Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.3 Panasonic
- 7.3.1 Panasonic Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.3.2 Panasonic Biobanking Product Portfolio
- 7.3.3 Panasonic Biobanking Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.4 SOL Group
- 7.4.1 SOL Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.4.2 SOL Group Biobanking Product Portfolio
- 7.4.3 SOL Group Biobanking Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.5 Promega
- 7.5.1 Promega Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.5.2 Promega Biobanking Product Portfolio
- 7.5.3 Promega Biobanking Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.6 Merck
- 7.6.1 Merck Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.6.2 Merck Biobanking Product Portfolio
- 7.6.3 Merck Biobanking Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.7 Greiner Bio One
- 7.7.1 Greiner Bio One Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.7.2 Greiner Bio One Biobanking Product Portfolio
- 7.7.3 Greiner Bio One Biobanking Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.8 Chart Industries
- 7.8.1 Chart Industries Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.8.2 Chart Industries Biobanking Product Portfolio
- 7.8.3 Chart Industries Biobanking Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.9 Brooks Life Science
- 7.9.1 Brooks Life Science Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.9.2 Brooks Life Science Biobanking Product Portfolio
- 7.9.3 Brooks Life Science Biobanking Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.10 Tecan Group
- 7.10.1 Tecan Group Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.10.2 Tecan Group Biobanking Product Portfolio
- 7.10.3 Tecan Group Biobanking Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.11 QIAGEN
- 7.11.1 QIAGEN Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.11.2 QIAGEN Biobanking Product Portfolio
- 7.11.3 QIAGEN Biobanking Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.12 BD
- 7.12.1 BD Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.12.2 BD Biobanking Product Portfolio
- 7.12.3 BD Biobanking Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.13 Lifeline Scientific
- 7.13.1 Lifeline Scientific Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.13.2 Lifeline Scientific Biobanking Product Portfolio
- 7.13.3 Lifeline Scientific Biobanking Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.14 Hamilton
- 7.14.1 Hamilton Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.14.2 Hamilton Biobanking Product Portfolio
- 7.14.3 Hamilton Biobanking Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.15 So-Low
- 7.15.1 So-Low Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.15.2 So-Low Biobanking Product Portfolio
- 7.15.3 So-Low Biobanking Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.16 TTP Labtech
- 7.16.1 TTP Labtech Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.16.2 TTP Labtech Biobanking Product Portfolio
- 7.16.3 TTP Labtech Biobanking Market Data Analysis (Revenue, Gross Margin and Market Share) (2021-2025)
- 7.17 Biolife Solutions
- 7.17.1 Biolife Solutions Basic Company Profile (Employees, Areas Service, Competitors and Contact Information)
- 7.17.
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
